Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$4.13 - $6.79 $93,974 - $154,499
22,754 New
22,754 $140,000
Q2 2023

Dec 19, 2023

SELL
$6.96 - $8.81 $322,867 - $408,687
-46,389 Reduced 82.74%
9,678 $68,000
Q2 2023

Aug 15, 2023

SELL
$6.96 - $8.81 $322,867 - $408,687
-46,389 Reduced 82.74%
9,678 $68,000
Q4 2022

Dec 19, 2023

BUY
$10.5 - $14.2 $588,703 - $796,151
56,067 New
56,067 $643,000
Q4 2022

Feb 15, 2023

SELL
$10.5 - $14.2 $34,450 - $46,590
-3,281 Reduced 5.53%
56,067 $644,000
Q3 2022

Nov 15, 2022

BUY
$10.79 - $14.81 $640,364 - $878,943
59,348 New
59,348 $748,000
Q1 2020

May 13, 2020

SELL
$1.6 - $4.11 $121,920 - $313,182
-76,200 Closed
0 $0
Q3 2019

Nov 15, 2019

BUY
$2.5 - $3.73 $190,500 - $284,226
76,200 New
76,200 $218,000

Others Institutions Holding BCRX

About BIOCRYST PHARMACEUTICALS INC


  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.41B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.